In addition, targeting CD4+ and CD8+ T cells to conserved regions that are subdominant in natural infection and/or that are not targeted by any currently licensed vaccines, is expected to provide an additional “layer” of protective immunity not currently seen in the infected and vaccinated population. This evidence concerns the gene CD8A and infection.